Low iron levels can be associated with feelings of fatigue, shortness of breath, dizziness, and lightheadedness
have any other medical conditions
Learn how to cancel your subscription No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego
Manufactured by: Mylan Institutional Galway, Ireland 0415L107 Revised: 9/2021 MI:VITBIJ:R4 PRINCIPAL DISPLAY PANEL - 30 mL PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 67457-146-30 30 mL Vitamin B-Complex 100 Injection For Intramuscular or Slow Intravenous Use Rx only Multi-Dose Vial Sterile Each mL contains: Thiamine HCl 100 mg, Riboflavin 5' Phosphate Sodium 2 mg, Pyridoxine HCl 2 mg, Dexpanthenol 2 mg, Niacinamide 100 mg, with Benzyl Alcohol 2% as preservative, in Water for Injection
Su clasificacin como inhibidor NNMT lo distingue de precursores del NAD+ y define su papel experimental en la investigacin metablica contempornea
Species 0.000 description 11 238000003786 synthesis reaction Methods 0.000 description 11 241000700159 Rattus Species 0.000 description 10 DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 9 PLRACCBDVIHHLZ-UHFFFAOYSA-N 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Chemical compound C1N(C)CCC(C=2C=CC=CC=2)=C1 PLRACCBDVIHHLZ-UHFFFAOYSA-N 0.000 description 8 101001135571 Mus musculus Tyrosine-protein phosphatase non-receptor type 2 Proteins 0.000 description 8 102000001189 Cyclic Peptides Human genes 0.000 description 7 108010069514 Cyclic Peptides Proteins 0.000 description 7 RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7 208000027418 Wounds and injury Diseases 0.000 description 7 239000000243 solution Substances 0.000 description 7 BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 6 FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 6 WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6 ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6 KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6 ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6 FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 6 FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6 RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 6 BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 6 238000004128 high performance liquid chromatography Methods 0.000 description 6 235000019155 vitamin A Nutrition 0.000 description 6 239000011719 vitamin A Substances 0.000 description 6 229940045997 vitamin a Drugs 0.000 description 6 DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 5 LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 5 QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 5 -1 aliphatic amino acid Chemical class 0.000 description 5 230000004071 biological effect Effects 0.000 description 5 239000003054 catalyst Substances 0.000 description 5 231100000517 death Toxicity 0.000 description 5 230000034994 death Effects 0.000 description 5 BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 5 229960003147 reserpine Drugs 0.000 description 5 MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 5 239000002904 solvent Substances 0.000 description 5 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 4 WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4 KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4 JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4 241000700605 Viruses Species 0.000 description 4 239000008280 blood Substances 0.000 description 4 210000004369 blood Anatomy 0.000 description 4 238000009833 condensation Methods 0.000 description 4 230000005494 condensation Effects 0.000 description 4 238000010647 peptide synthesis reaction Methods 0.000 description 4 229920000642 polymer Polymers 0.000 description 4 235000018102 proteins Nutrition 0.000 description 4 108090000623 proteins and genes Proteins 0.000 description 4 102000004169 proteins and genes Human genes 0.000 description 4 239000011347 resin Substances 0.000 description 4 229920005989 resin Polymers 0.000 description 4 VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 3 208000009132 Catalepsy Diseases 0.000 description 3 UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3 WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3 VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3 241000779819 Syncarpia glomulifera Species 0.000 description 3 WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3 206010044565 Tremor Diseases 0.000 description 3 206010047853 Waxy flexibility Diseases 0.000 description 3 206010052428 Wound Diseases 0.000 description 3 230000000840 anti-viral effect Effects 0.000 description 3 230000008878 coupling Effects 0.000 description 3 238000010168 coupling process Methods 0.000 description 3 238000005859 coupling reaction Methods 0.000 description 3 208000035475 disorder Diseases 0.000 description 3 230000035876 healing Effects 0.000 description 3 208000005252 hepatitis A Diseases 0.000 description 3 230000006698 induction Effects 0.000 description 3 238000011835 investigation Methods 0.000 description 3 UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 3 230000000144 pharmacologic effect Effects 0.000 description 3 239000001739 pinus spp
